Share on Pinterest Bemotrizinol (PARSOL Shield), an advanced sunscreen filter that has long been used in Europe and Asia, has been approved for use in the U.S. by the FDA. Image Credit: Photo by LumiNola/Getty Images The FDA has approved bemotrizinol (PARSOL Shield). This is the first new sunscreen ingredient approved in over 20 years, offering superior UVA and UVB protection. Consumers in the United States can expect new products featuring PARSOL Shield by the end of 2026, with broader availability to follow. This innovation closes the UVA protection gap and paves the way for more effective, cosmetically elegant sunscreens. The Food and Drug Administration (FDA) has approved bemotrizinol (PARSOL Shield), an advanced sunscreen filter that has long been used in Europe and Asia. “It introduces a modern UV filter that has been used safely and effectively in Europe and other parts of the world for many years. One longstanding criticism of the U.S. sunscreen market has been that consumers have had access to fewer advanced UV filters than those available internationally,” she said. “This gives formulators greater flexibility to…
- Ingredient signalCoverage centres on sunscreen, pay attention to concentration, vehicle, and pairings in your routine before changing anything material.
Sunscreen use and the prevention of photoaging: a 4.5-year randomized controlled trial
A 4.5-year RCT showed daily SPF 15 reduces skin aging by 24% measured objectively. There is no anti-aging serum with this evidence base. Daily SPF is the single highest-leverage intervention.
Sun protection factor and photoprotection: evidence-based recommendations
Daily SPF is the single most evidence-backed anti-aging step. A 4.5-year study found it reduces melanoma risk by 50% and visible photoaging by 24%. Mineral SPF is best for sensitive and acne-prone skin.
This intelligence brief synthesizes reporting from beauty and dermatology industry publications.
View source →